Thus, this study aimed to perform molecular simulation studies of 17β-AEs with GPER1, and corroborate their proliferative effects in cancer cell lines to assess whether these compounds represent potential therapeutic options for HRT in women going through menopause. The gene discussed is GPER1; the disease is cancer.